Further exploration found that for AAs with T2DM, renal apolipoprotein L1 (APOL1) risk variants were associated with decreased cerebral WML volume and larger GM volume (125), although the association between APOL1 risk variants and changes in cognitive function remains unclear. The gene discussed is APOL1; the disease is type 2 diabetes mellitus.